Launch week offerEnds in00h00m00s

annual Promonthly Pro

Branko Cuglievan

Associate Professor, Chief of Pediatric Hematological Malignancies

The University of Texas MD Anderson Cancer Center Children's Cancer Hospital

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (13)

sairah ahmed

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Amber Gibson

Assistant Professor

The University of Texas MD Anderson Cancer Center Children's Cancer Hospital

UNITED STATES

View details

Alex Bataller Torralba

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Guilin Tang

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Ghayas C. Issa

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Michele S. Redell

Professor

Baylor College of Medicine

UNITED STATES

View details

Sanam Loghavi

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Samanta Catueno

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

David McCall

UNITED STATES

View details

Warren Fiskus

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Megan Othus

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Yesid Alvarado Valero

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Courtney D. DiNardo

University of Pennsylvania

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Branko Cuglievan

Research Interests

Make your next move.

Explore related searches

Articles (20)

All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Immunophenotypic changes following menin inhibition in acute myeloid leukemia

Immune‐related toxicity profile after haematopoietic stem cell transplantation in patients with B‐ALL given combination immunotherapy with rituximab, inotuzumab and blinatumomab

Uncommon Presentation and Therapeutic Strategies in Pediatric Relapsed/Refractory ALK-Positive ALCL

Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high‐risk MECOM‐rearranged AML

Beyond Cellular Therapies: The Expanding Role of Antibody-Driven Immunotherapy in Pediatric Acute Lymphoblastic Leukemia

High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition

Opinion: a call for safe therapeutic and gastric interventions for adolescents and young adults with obesity and transplant-indicated leukemia

Performance Evaluation of a Novel Non-Invasive Monitoring Device for At-Home Neutropenia Detection in a Multicenter Cancer Cohort

Reconsidering Asparaginase in Leukemia Therapy

Revumenib as maintenance for AML following allogeneic stem cell transplantation.

Survival After Diagnosis of Cardiovascular Disease in Survivors of Adolescent and Young Adult Lymphoma

Ten-year long-term survivors of blastic plasmacytoid dendritic cell neoplasm (BPDCN)

Designing Clinical Trials for Patients With Rare Cancers: Connecting the Zebras

Calasparagase Pegol Induced Hemolytic Anemia

Characteristics and outcomes of newly diagnosed pediatric acute myeloid leukemia patients who were removed from standard regimens and received alternative therapy

Acute Leukemia in the Crosshairs: First-in-Class Menin Inhibitor Approval for Adults and Children

Cardiac safety of revumenib in children with HOX-driven leukemia: A single-institution cohort

Clinical, cytogenetic and molecular characteriszation of Mecom- rearranged pediatric de novo Acute Myeloid Leukemia (AML): A retrospective cohort study of the international-berlin-frankfurt-Munster (I-BFM) AML-study group

Co-targeting menin and RAS in KMT2A-r/NPM1c AML with activated RTK//RAS/MAPK signaling

Collaborators (13)

sairah ahmed

Amber Gibson

Alex Bataller Torralba

Guilin Tang

Ghayas C. Issa

Michele S. Redell

Sanam Loghavi

Samanta Catueno

David McCall

Warren Fiskus

Megan Othus

Yesid Alvarado Valero

Courtney D. DiNardo

Make your next move.